FI952804A0 - Substituerade bensazepinoner - Google Patents

Substituerade bensazepinoner

Info

Publication number
FI952804A0
FI952804A0 FI952804A FI952804A FI952804A0 FI 952804 A0 FI952804 A0 FI 952804A0 FI 952804 A FI952804 A FI 952804A FI 952804 A FI952804 A FI 952804A FI 952804 A0 FI952804 A0 FI 952804A0
Authority
FI
Finland
Prior art keywords
benzazepinones
substituted
substituted benzazepinones
Prior art date
Application number
FI952804A
Other languages
English (en)
Finnish (fi)
Other versions
FI952804A (sv
Inventor
Peter Buehlmayer
Pascal Furet
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI952804A0 publication Critical patent/FI952804A0/sv
Publication of FI952804A publication Critical patent/FI952804A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI952804A 1992-12-11 1995-06-07 Substituerade bensazepinoner FI952804A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH380292 1992-12-11
PCT/EP1993/003425 WO1994013642A1 (de) 1992-12-11 1993-12-06 Substituierte benzazepinone

Publications (2)

Publication Number Publication Date
FI952804A0 true FI952804A0 (sv) 1995-06-07
FI952804A FI952804A (sv) 1995-06-07

Family

ID=4263766

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952804A FI952804A (sv) 1992-12-11 1995-06-07 Substituerade bensazepinoner

Country Status (11)

Country Link
US (1) US5683997A (sv)
EP (1) EP0673369A1 (sv)
JP (1) JPH08506097A (sv)
KR (1) KR950704259A (sv)
AU (1) AU685767B2 (sv)
CA (1) CA2151380A1 (sv)
FI (1) FI952804A (sv)
HU (1) HUT71557A (sv)
NO (1) NO952289L (sv)
NZ (1) NZ258888A (sv)
WO (1) WO1994013642A1 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1103552A4 (en) 1998-08-07 2003-01-15 Takeda Chemical Industries Ltd BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
EP1013273A1 (en) * 1998-12-23 2000-06-28 Novartis AG Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
US6465502B1 (en) 1998-12-23 2002-10-15 Novartis Ag Additional therapeutic use
CA2351357A1 (en) * 1998-12-23 2000-07-06 Novartis Ag Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors
IT1308613B1 (it) * 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
US6211217B1 (en) 1999-03-16 2001-04-03 Novartis Ag Method for reducing pericardial fibrosis and adhesion formation
US8642051B2 (en) * 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
ITMI20010129A1 (it) * 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
EP1382334A1 (en) * 2002-07-11 2004-01-21 Université de Picardie Jules Verne Use of angiotensin II AT1-receptor blockers (ARB), alone or combined with thiazide or angiotensin II for the treatment of stroke
CA2575706A1 (en) * 2004-08-02 2006-02-23 Bebaas, Inc. Vitamin b12 compositions
ES2425567T3 (es) 2004-12-24 2013-10-16 Spinifex Pharmaceuticals Pty Ltd Método de tratamiento o profilaxis
US20070178141A1 (en) * 2005-09-07 2007-08-02 Bebaas, Inc. Vitamin B12 compositions
US20130131007A1 (en) 2005-09-07 2013-05-23 Bebaas, Inc. Vitamin b12 compositions
CN102885818B (zh) * 2006-03-20 2016-05-04 诺华股份有限公司 治疗或预防炎性痛的方法
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1266647A (en) * 1984-06-26 1990-03-13 William H. Parsons Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists
EP0166354B1 (en) * 1984-06-26 1992-08-05 Merck & Co. Inc. Benzofused lactam compounds and pharmaceutical compositions containing them
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
US5206235A (en) * 1991-03-20 1993-04-27 Merck & Co., Inc. Benzo-fused lactams that promote the release of growth hormone

Also Published As

Publication number Publication date
CA2151380A1 (en) 1994-06-23
US5683997A (en) 1997-11-04
NO952289D0 (no) 1995-06-09
EP0673369A1 (de) 1995-09-27
HU9501695D0 (en) 1995-08-28
AU5696694A (en) 1994-07-04
AU685767B2 (en) 1998-01-29
WO1994013642A1 (de) 1994-06-23
NO952289L (no) 1995-06-09
JPH08506097A (ja) 1996-07-02
KR950704259A (ko) 1995-11-17
NZ258888A (en) 1997-02-24
FI952804A (sv) 1995-06-07
HUT71557A (en) 1995-12-28

Similar Documents

Publication Publication Date Title
AT399443B (de) Sportschuh
ATE172738T1 (de) Substituierte 6-aza-androstenone
NO952289D0 (no) Substituerte benzazepinoner
BR9305745A (pt) Quebra-luz
ATA236892A (de) Rotornut
DE59309389D1 (de) Substituierte Thiophencarbonsäureamide
ATA227792A (de) Sportschuh
DE59310082D1 (de) Substituierte 2-arylpyrrole
BR7201352U (pt) Luninaria
BR9200611A (pt) Hidrocofre
ATA27393A (de) Alpinski
ATA58493A (de) Lochstein
BR7200188U (pt) Hidro-cinzeiro
BR7200229U (pt) Doca-dupla
BR7200240U (pt) Vari-watt
BR7200318U (pt) Cabide sanfonado
BR7200879U (pt) Cocho saleiro biazi
ATA256392A (de) Bandräumer
BR9203234A (pt) Sofa-mesa
BR7202026U (pt) Aero-mala
BR9200231A (pt) Agrupador
BR9200295A (pt) Aurissima
BR9200296A (pt) Varre-lava
BR9200298A (pt) Microsisten-telesupervisao
BR9200554A (pt) Lixoduto

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed